S&P 500
(-0.15%) 5 460.85 points
Dow Jones
(-0.13%) 39 062 points
Nasdaq
(0.11%) 17 737 points
Oil
(-0.12%) $80.73
Gas
(-3.70%) $2.65
Gold
(-0.70%) $2 314.50
Silver
(0.20%) $28.93
Platinum
(1.97%) $1 005.80
USD/EUR
(0.32%) $0.936
USD/NOK
(0.76%) $10.68
USD/GBP
(0.50%) $0.792
USD/RUB
(0.01%) $87.50

के लिए वास्तविक समय के अद्यतन Halozyme Therapeutics Inc [HALO]

एक्सचेंज: NASDAQ क्षेत्र: Healthcare उद्योग: Biotechnology
BUY
83.33%
return 6.31%
SELL
50.00%
return 0.91%
अंतिम अद्यतन26 Jun 2024 @ 20:57

-0.89% $ 51.94

खरीदें 117 min ago

@ $51.96

जारी किया गया: 26 Jun 2024 @ 19:01


वापसी: -0.04%


पिछला सिग्नल: Jun 25 - 22:44


पिछला सिग्नल: बेचें


वापसी: -0.96 %

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 20:57):
Our systems believe the stock currently is undervalued by 0.17% compare to its pairs and should correct upwards.

Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally...

Stats
आज की मात्रा 290 982
औसत मात्रा 1.13M
बाजार मूल्य 6.61B
EPS $0.610 ( Q1 | 2024-05-07 )
अगली कमाई की तारीख ( $0 ) 2024-08-06
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 21.55
(Sector) 42.63
(Industry) 24.32
ATR14 $0.630 (1.21%)
AADI -2.65%
ABCL 1.65%
ABCM 0.04%
ABEO -2.84%
ABIO -1.68%
ABOS 1.64%
ABSI 2.89%
ABUS -2.24%
ABVX -3.53%
ACAD -0.67%
ACER -17.95%
ACET -4.76%
ACGN 1.29%
ACHL -3.00%
ACHV -1.83%
ACIU -1.00%
ACLX -0.04%
ACRV -4.79%
ACST -1.63%
ACXP 0.65%
ADAG 4.64%
ADAP -2.91%
ADGI 0.87%
ADIL 0.54%
ADMA -2.72%
ADPT -0.30%
ADTX -3.47%
ADVM -3.91%
ADXN -1.60%
AEON -3.74%
AEZS -3.51%
AFMD -1.40%
AGEN -1.58%
AGIO -2.04%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -3.39%
AKRO -2.81%
AKTX 4.08%
AKUS 0.00%
ALBO 0.00%
ALDX -2.40%
ALEC -3.90%
ALGS -2.41%
ALKS -0.21%
ALLK -8.47%
ALLO -6.46%
ALLR -3.17%
ALNA 3.16%
ALNY 1.76%
ALPN 0.02%
ALPX 0.00%
ALRN -0.34%
ALT -9.54%
ALVR 0.92%
ALXN 0.00%
ALXO -10.96%
ALZN 4.78%
AMRN -0.31%
AMTI -3.13%
ANAB 0.50%
ANEB -1.52%
ANGN 0.00%
ANIX -1.62%
ANL -6.60%
ANNX -0.65%
ANPC -3.15%
APGE -1.01%
APGN 8.48%
APGNW 30.65%
APLM 1.56%
APLS 0.00%
APLT -4.50%
APM -1.47%
APOP 0.38%
APRE 2.29%
APTO 3.27%
APTX 3.17%
APVO 0.18%
ARAV -13.39%
ARCT -3.84%
ARDS -14.23%
ARDX -0.83%
ARGX -0.81%
ARNA 0.00%
ARPO -0.90%
ARQT -0.62%
ARTL -2.50%
ARTLW 0.00%
ARVN 5.69%
ARWR -1.86%
ASLN -4.71%
ASMB -7.14%
ASND -0.91%
ATAI -1.11%
ATHA 5.94%
ATHE 1.12%
ATHX -33.50%
ATNF 0.99%
ATOS 3.40%
ATRA -3.45%
ATXI 1.93%
ATXS -0.89%
AUPH -1.17%
AURA -0.15%
AUTL -1.72%
AVBP -2.86%
AVEO 0.00%
AVIR -0.15%
AVRO -1.41%
AVTE -5.54%
AVTX -1.25%
AVXL -2.96%
AXLA 0.00%
AXSM -1.75%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 0.81%
BCAB 3.59%
BCDA -2.07%
BCDAW -41.77%
BCEL 0.00%
BCLI 7.14%
BCRX 1.15%
BCTX 7.61%
BCTXW -21.24%
BCYC 0.83%
BDRX -3.52%
BDTX -0.85%
BEAM 0.17%
BFRA -2.91%
BGNE -2.72%
BIOR -3.40%
BIVI 1.27%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.85%
BLTE -0.62%
BLU 0.03%
BLUE -0.52%
BMEA -9.96%
BMRN 0.39%
BNOX -2.22%
BNTC -2.11%
BNTX -1.58%
BOLD -7.90%
BOLT 1.31%
BPMC -1.27%
BPTH 1.86%
BPTS -13.47%
BRNS -0.74%
BRTX -2.36%
BTAI 23.31%
BTTX 53.33%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 3.33%
CABA 0.62%
CADL -0.97%
CALA 0.00%
CALC -1.77%
CALT -0.59%
CAPR -2.80%
CARA 0.21%
CARM 12.13%
CASI -1.67%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -6.90%
CCCC -5.52%
CCXI 0.00%
CDAK 0.00%
CDIO -2.02%
CDIOW 24.00%
CDMO -3.10%
CDMOP 0.04%
CDT -10.57%
CDTTW -39.60%
CDTX -1.92%
CDXC 0.00%
CDXS 4.83%
CELC -4.25%
CELU -1.50%
CELUW 11.80%
CERC -1.68%
CERE -0.99%
CERO -3.40%
CEROW -10.18%
CFRX -27.95%
CGEM -2.50%
CGEN -3.31%
CGON -0.48%
CGTX -5.11%
CHMA -6.00%
CHRS -0.32%
CINC 0.00%
CING 2.56%
CINGW 34.95%
CKPT -2.88%
CLBS -16.75%
CLDX -2.26%
CLGN 0.34%
CLLS -4.15%
CLNN 2.42%
CLNNW 0.00%
CLRB 7.04%
CLSD 1.60%
CLSN -0.68%
CLVS 0.00%
CMMB -0.01%
CMND 3.63%
CMPI 0.00%
CMPX -8.03%
CMRA 0.00%
CMRAW 33.33%
CMRX -2.71%
CNCE 0.00%
CNSP -39.90%
CNST 0.00%
CNTA -0.67%
CNTB -2.25%
CNTX -6.85%
COCP -2.02%
COEPW 32.45%
COGT -3.12%
CORT 2.20%
COYA -1.46%
CPRX -0.86%
CRBP -1.88%
CRBU -4.83%
CRDF -1.77%
CRGX 1.28%
CRIS -0.38%
CRNX -5.71%
CRSP 0.82%
CRTX 2.63%
CRVO -2.50%
CRVS 1.12%
CSBR -1.59%
CTCX -1.63%
CTIC 0.06%
CTMX -3.31%
CTNM -0.65%
CTXR 1.43%
CUE 3.60%
CVAC -2.26%
CVKD -5.23%
CWBR 2.80%
CYAD -12.96%
CYCC 9.75%
CYCCP 5.49%
CYCN 0.43%
CYT -2.27%
CYTK -2.04%
CYTO -2.73%
DARE 7.54%
DAWN 0.60%
DBTX -0.81%
DBVT 4.44%
DFFN 10.28%
DICE 0.06%
DMAC 30.22%
DNLI -1.61%
DNTH -6.31%
DOMH -1.58%
DRMA -1.10%
DRMAW -1.25%
DRNA 0.00%
DRTS 1.85%
DRTSW 0.00%
DRUG 0.95%
DSGN -1.21%
DTIL 1.36%
DYAI 9.68%
EARS -1.77%
EDIT -2.61%
EDSA -1.00%
EFTR 8.18%
EFTRW -51.85%
EIGR -9.21%
ELAB -1.00%
ELDN 7.98%
ELEV -4.98%
ELOX 7.69%
ELTX -0.88%
ELVN -3.87%
ELYM 1.05%
ENGN 1.67%
ENGNW 0.12%
ENLV 2.54%
ENOB 1.79%
ENSC 5.11%
ENTA -0.49%
ENTO -4.42%
ENTX 0.69%
ENVB 1.10%
EPIX -0.10%
EPRX -2.97%
EPZM 0.00%
EQ 0.86%
EQRX -2.09%
EQRXW 0.00%
ERAS -1.20%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 87.05%
ETNB -0.83%
ETON 1.68%
ETTX 0.00%
EVAX -2.14%
EVGN 3.88%
EVLO 0.00%
EWTX -0.06%
EXAI -0.94%
EXEL -0.36%
EYEG -0.69%
EYEN 1.48%
EYPT -0.12%
FATE -7.93%
FBIO 0.59%
FBIOP 0.92%
FBLG -14.69%
FBRX -0.04%
FDMT -4.86%
FENC -0.97%
FGEN -5.53%
FHTX 1.43%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -2.68%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -0.31%
FULC -3.18%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -6.42%
GANX -1.49%
GBIO -2.12%
GBT 0.01%
GDTC 0.50%
GERN -4.31%
GHRS -1.59%
GLMD -2.32%
GLPG -2.26%
GLSI 2.80%
GLTO -0.57%
GLUE -1.58%
GLYC -10.00%
GMAB -0.43%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -0.52%
GNLX 1.33%
GNPX 0.00%
GNTA 3.94%
GOSS -9.59%
GOVX 5.46%
GOVXW -49.04%
GPCR -6.49%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -0.08%
GRTX 0.00%
GTHX 0.45%
GUTS -5.31%
GXGXW 41.67%
GYRE -7.16%
HALO -0.89%
HARP 0.09%
HCWB -3.75%
HEPA 2.80%
HGEN -84.62%
HILS 5.66%
HLVX -0.77%
HOOK 1.13%
HOTH -2.70%
HOWL -2.14%
HRMY 0.85%
HRTX 1.80%
HSTO 0.00%
HUMA 2.03%
HUMAW -0.01%
IBRX -4.47%
ICCC 0.22%
ICPT 0.21%
ICU 16.82%
ICUCW 20.20%
ICVX -0.91%
IDRA -23.04%
IDYA -1.61%
IFRX -1.85%
IGMS -0.15%
IKNA 0.60%
IKT 1.42%
IMAB -0.58%
IMCR -2.61%
IMGN 0.02%
IMGO 0.00%
IMMP 4.55%
IMMX -6.90%
IMNM -1.56%
IMNN 0.88%
IMPL -27.27%
IMRA 15.96%
IMRN -1.18%
IMRX 0.00%
IMTX -1.58%
IMTXW 6.00%
IMUX 1.56%
IMV 0.00%
IMVT -3.66%
INAB 0.00%
INBX 0.46%
INCY -0.98%
INDP 11.07%
INFI -52.38%
INKT -0.01%
INM -2.20%
INMB 2.66%
INO -1.82%
INSM -0.85%
INTS -2.75%
INVA 0.25%
INZY 0.91%
IOBT -11.42%
IONS 0.44%
IOVA -2.31%
IPA 2.46%
IPHA 5.58%
IPSC -1.95%
IRON -2.79%
ISEE 0.38%
ITOS -1.44%
ITRM 1.67%
IVA 6.96%
IVVD -3.72%
JAGX 1.04%
JANX -4.02%
JAZZ -0.51%
JNCE 0.00%
JSPR -5.92%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.94%
KALV -1.90%
KDNY 0.22%
KMPH -0.34%
KNSA -2.71%
KNTE -0.38%
KOD -7.11%
KPRX 0.96%
KPTI -1.38%
KRBP -10.00%
KRON 1.05%
KROS -1.20%
KRRO -6.34%
KRTX 0.03%
KRYS -0.99%
KTRA 16.92%
KTTA 8.16%
KTTAW 0.92%
KURA -1.83%
KYMR -2.41%
KYTX -4.62%
KZIA 5.16%
KZR -1.49%
LABP 0.57%
LBPH -1.71%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.60%
LENZ -4.01%
LEXX 0.00%
LEXXW -14.63%
LGND -1.30%
LGNDV 0.00%
LGVN -9.63%
LIAN -8.28%
LIFE 2.70%
LIPO -7.10%
LIXT -5.24%
LIXTW 63.57%
LJPC -0.32%
LMNL 0.12%
LOGC 0.70%
LPCN -4.05%
LPTX -1.10%
LQDA -0.24%
LRMR -1.78%
LSTA -4.06%
LTRN 1.76%
LUMO -1.32%
LVTX 0.00%
LXEO -4.33%
LXRX -2.35%
LYEL -34.83%
LYRA 2.33%
MACK 0.10%
MBIO -9.07%
MBRX -1.72%
MCRB 1.72%
MDGL -2.42%
MDNA -13.16%
MDWD 0.10%
MDXG -2.58%
MEIP -0.13%
MESO -1.78%
MGNX -3.03%
MGTA -7.74%
MGTX -2.97%
MGX -2.68%
MIRM -1.55%
MIRO 0.59%
MIST 1.54%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX -0.63%
MLYS -5.67%
MNKD -1.05%
MNMD 0.21%
MNOV 2.11%
MNPR -5.01%
MOLN 0.28%
MOR 1.18%
MORF -3.78%
MREO -4.28%
MRKR 2.68%
MRNA -4.99%
MRNS -4.04%
MRSN -2.41%
MRTX -0.17%
MRUS 0.15%
MRVI -1.82%
MTCR -1.29%
MTEM 4.46%
MTP -18.50%
MURA -1.24%
MYMD 8.38%
NAMS 1.37%
NAMSW 0.43%
NAUT 1.14%
NBRV 0.71%
NBSE -1.56%
NBTX 8.61%
NCNA 1.09%
NERV -1.87%
NEXI 2.60%
NGM -1.28%
NGNE -2.03%
NKGN 5.88%
NKGNW 8.00%
NKTR -3.74%
NKTX -4.57%
NLSP -2.82%
NLSPW 26.67%
NMRA -0.91%
NMTR -42.97%
NOVN -24.84%
NRBO 12.11%
NRIX -0.38%
NRSN -7.05%
NRSNW 0.00%
NRXP -4.14%
NRXPW 18.33%
NRXS 4.82%
NTBL 5.06%
NTEC -12.45%
NTHI 0.00%
NTLA -6.19%
NTRBW -31.07%
NUVL -2.00%
NVAX -2.29%
NVCT 3.59%
NVIV -34.28%
NXTC -2.94%
NYMX -0.05%
OABI 0.26%
OABIW -10.06%
OBIO -2.99%
OBSV 0.00%
OCEA 0.00%
OCGN 4.26%
OCS -1.02%
OCUL -1.91%
OCUP 1.96%
ODT -4.27%
OKYO 1.51%
OLMA -5.54%
OMER -1.03%
OMGA 5.00%
ONCO 5.04%
ONCR -3.08%
ONCS 31.87%
ONCT -1.87%
ONCY 0.99%
ONTX -0.47%
ONVO 0.99%
OPNT 0.00%
OPT 3.09%
ORGS -2.07%
ORIC -3.56%
ORMP 15.09%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -1.81%
OVID -1.46%
OYST 0.00%
PALI -0.87%
PASG -1.30%
PBLA -7.50%
PBM -7.64%
PBYI 1.69%
PCSA 0.00%
PCVX -0.43%
PDSB -1.65%
PEPG -0.60%
PGEN -2.99%
PHAR 1.51%
PHAS 0.00%
PHAT -1.06%
PHIO -3.57%
PHIOW 36.47%
PHVS -7.22%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -0.73%
PLUR 6.01%
PMN 0.72%
PMVP -1.19%
PNT 0.16%
PPBT -4.26%
PRAX 0.84%
PRDS 0.93%
PRLD 0.00%
PROG -3.47%
PROK 0.22%
PRQR -0.01%
PRTA -2.46%
PRTC 0.49%
PRTG -0.50%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -5.11%
PSTX -0.97%
PTCT -0.50%
PTE -0.82%
PTGX -1.70%
PTIXW -49.04%
PULM 2.60%
PXMD 0.00%
PYPD 0.07%
PYXS 2.29%
QLGN -3.72%
QNCX 5.70%
QNRX 0.37%
QSI -11.88%
QSIAW -3.13%
QTTB -4.54%
QURE -0.22%
RAIN -1.63%
RANI 6.42%
RAPT -2.92%
RARE 1.10%
RCKT -8.26%
REGN -0.70%
RENB -3.42%
REPL -3.00%
RETA 0.02%
REUN -0.89%
REVB -1.40%
REVBU 3.46%
REVBW 4.38%
RGLS -4.91%
RGNX -5.59%
RIGL -3.28%
RLAY -4.74%
RLMD 0.33%
RLYB -0.34%
RNA -0.49%
RNAC -5.65%
RNAZ -0.96%
RNXT 1.88%
ROIV -2.08%
ROIVW 4.56%
RPHM 0.00%
RPRX 0.28%
RPTX -2.93%
RUBY 2.70%
RVLP -32.05%
RVMD -1.20%
RVMDW -30.00%
RVNC 2.13%
RVPH -1.58%
RVPHW 1.62%
RXDX 0.09%
RXRX -3.30%
RYTM -6.46%
RYZB 0.02%
RZLT 1.68%
SABS -1.37%
SABSW -11.81%
SAGE 1.56%
SANA -3.97%
SAVA -0.26%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 5.50%
SCPH -0.51%
SCPS 0.00%
SEEL -4.48%
SEER 0.00%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -1.03%
SGMT -1.93%
SGTX -2.56%
SIOX 22.63%
SLDB -7.07%
SLGL 4.00%
SLN -4.21%
SLNO -3.74%
SLRX 6.69%
SLS -2.99%
SMMT -2.56%
SNDX 0.84%
SNGX -3.02%
SNPX -0.81%
SONN -1.08%
SPPI -0.49%
SPRB 0.32%
SPRC -4.17%
SPRO 0.30%
SRNE -34.00%
SRPT -1.81%
SRRA 0.00%
SRRK -2.60%
SRZN -2.45%
STAB 0.00%
STOK -5.10%
STRO -2.84%
STSA 0.00%
STTK -4.79%
SURF -0.93%
SVRA -3.03%
SWTX 0.22%
SYBX -1.94%
SYRS -1.72%
TALS -0.73%
TARA -6.90%
TARS 0.12%
TBPH 0.60%
TCBP 2.73%
TCDA 0.00%
TCON -2.03%
TCRR 0.00%
TCRT 1.59%
TCRX 2.58%
TECH -0.23%
TENX -1.27%
TERN -7.70%
TFFP -3.05%
TGTX -2.94%
THRX 0.12%
TIL -0.20%
TLC 0.00%
TLSA -4.13%
TNGX -2.16%
TNXP -6.39%
TNYA -8.23%
TPST 2.43%
TRDA -3.86%
TRVI 1.15%
TRVN 2.92%
TSHA -24.30%
TSVT -3.19%
TTNP -9.27%
TVTX 0.63%
TYRA -7.09%
UBX -2.12%
UNCY -3.73%
URGN -1.46%
UTHR -0.32%
VACC 11.36%
VALN -2.89%
VAXX 99.94%
VBIV 0.78%
VBLT -8.77%
VCEL -0.09%
VCNX 10.35%
VCYT -1.28%
VERA -2.74%
VERU 0.78%
VERV -3.06%
VIGL 5.11%
VINC 1.62%
VIR 0.00%
VIRI -1.57%
VIRX 2.40%
VKTX -1.67%
VLON -13.04%
VNDA -2.28%
VOR -2.02%
VRCA -0.07%
VRDN -4.31%
VRNA -1.53%
VRPX 0.38%
VRTX 0.35%
VSTM -3.74%
VTGN -0.45%
VTVT -2.97%
VTYX -0.21%
VXRT -2.59%
VYGR -1.66%
VYNE -3.47%
VYNT 7.78%
WINT -3.24%
WVE -4.40%
XBIO 0.93%
XBIT 1.77%
XCUR 3.58%
XENE -3.11%
XERS 2.86%
XFOR 2.86%
XLO 2.00%
XLRN 0.00%
XNCR 0.47%
XOMA -3.14%
XOMAO 0.36%
XOMAP -0.82%
XRTX -8.92%
YMAB -1.80%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -3.51%
ZNTL -2.62%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-18 Labarre Michael J. Buy 10 000 Common Stock
2024-06-18 Labarre Michael J. Sell 10 000 Common Stock
2024-06-18 Labarre Michael J. Sell 10 000 Option to Purchase Common Stock
2024-06-12 Snyder Mark Howard Buy 20 137 Restricted Stock Units
2024-06-11 Posard Matthew L. Sell 10 000 Common Stock
INSIDER POWER
28.88
Last 99 transactions
Buy: 693 734 | Sell: 376 433
सहसंबंध (AI algo v.1.1b): Undervalued: 0.17% $52.02 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: 0.57 (weak)
छोटा: -0.97 (very strong negative)
Signal:(50) Neutral

Halozyme Therapeutics Inc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
AGIO0.904
VEON0.894
TXRH0.888
MACK0.885
ULBI0.885
PHO0.883
SCSC0.883
LMAT0.882
AQWA0.881
NXPI0.876
10 सबसे अधिक नकारात्मक सहसंबंध
CYAN-0.85
VREX-0.849
REKR-0.845
HMNF-0.843
HSDT-0.839
CCRN-0.839
SYPR-0.838
WTER-0.838
CNTG-0.834
IMKTA-0.833

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Halozyme Therapeutics Inc सहसंबंध - मुद्रा/वस्त्र

The country flag -0.03
( neutral )
The country flag -0.44
( neutral )
The country flag 0.00
( neutral )
The country flag -0.21
( neutral )
The country flag 0.00
( neutral )
The country flag 0.11
( neutral )

Halozyme Therapeutics Inc वित्तीय

Annual 2023
राजस्व: $829.25M
सकल लाभ: $636.89M (76.80 %)
EPS: $2.13
FY 2023
राजस्व: $829.25M
सकल लाभ: $636.89M (76.80 %)
EPS: $2.13
FY 2022
राजस्व: $660.12M
सकल लाभ: $520.81M (78.90 %)
EPS: $1.480
FY 2021
राजस्व: $443.31M
सकल लाभ: $361.90M (81.64 %)
EPS: $2.84

Financial Reports:

No articles found.

Halozyme Therapeutics Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Halozyme Therapeutics Inc

Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its flagship product is Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in subcutaneous urography and to improve resorption of radiopaque agents. The company also develops Perjeta; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; and ViiV Healthcare Limited for small and large molecule targets for the treatment and prevention of HIV. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.

के बारे में लाइव सिग्नल्स

इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।

लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं

Total Execution Time: 1.3261089324951 seconds
Number of API calls: 3
Number of DB calls: 9